This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pui CH and Evans WE (2006) Drug therapy: treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166–178
Attal M et al. (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495–2502
Abdelkefi A et al. (2007) Single autologous stem cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial. Blood [doi:10.1182/blood-2007-07-101212]
Shaughnessy JD Jr et al. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109: 2276–2284
Acknowledgements
The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
van Rhee, F. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?. Nat Rev Clin Oncol 5, 70–71 (2008). https://doi.org/10.1038/ncponc1005
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncponc1005